Roundtable: Global (1) – Preparing Acquired Product Portfolios for Future Disputes
Many acquired life science and technology assets enter litigation without the technical documentation, invention history and institutional knowledge needed to support successful enforcement or defence strategies. Drawing on practical case studies, this roundtable explores how companies can better prepare acquired and in-licensed assets for future disputes by preserving critical evidence and proactively managing downstream litigation risk.